Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
BeyondSpring Set to Join FTSE Russell 3000® Index | ||
By: Nasdaq / GlobeNewswire - 20 Jun 2019 | Back to overview list |
|
NEW YORK, June 20, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, announced today that it will join the FTSE Russell 3000® Index at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the U.S. market opens on July 1, 2019, according to a preliminary list of additions posted June 7, 2019. Membership in the Russell 3000® Index, which remains in place for one year, means the automatic inclusion of BeyondSpring common stock in index funds designed to track stocks included in the Russell 3000® Index. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “Being added to the Russell Index is a significant accomplishment for the Company and validates our growth potential," said Dr. Lan Huang, CEO of BeyondSpring. “We continue to develop a robust pipeline and are advancing our lead first-in-class asset, Plinabulin, a direct anticancer agent in the treatment of non-small cell lung cancer (NSCLC), as well as in prevention of chemotherapy-induced neutropenia (CIN), through global Phase 3 clinical trials.” Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell's U.S. indexes. Russell indexes are part of FTSE Russell, a leading global index provider. About BeyondSpring Cautionary Note Regarding Forward-Looking Statements Contact: Media Relations: |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |